Bernard L Kasten - Net Worth and Insider Trading
Bernard L Kasten Net Worth
The estimated net worth of Bernard L Kasten is at least $97,945 dollars as of 2024-11-13. Bernard L Kasten is the Director of Cleveland BioLabs Inc and owns about 22,516 shares of Cleveland BioLabs Inc (CBLI) stock worth over $97,945. Bernard L Kasten is also the Director of Enzo Biochem Inc and owns about 0 shares of Enzo Biochem Inc (ENZ) stock worth over $0. Details can be seen in Bernard L Kasten's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bernard L Kasten has not made any transactions after 2016-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bernard L Kasten
Bernard L Kasten Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bernard L Kasten owns 5 companies in total, including Enzo Biochem Inc (ENZ) , Cleveland BioLabs Inc (CBLI) , and Genelink Inc (GNLKQ) among others .
Click here to see the complete history of Bernard L Kasten’s form 4 insider trades.
Insider Ownership Summary of Bernard L Kasten
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ENZ | Enzo Biochem Inc | 2016-03-11 | director |
CBLI | Cleveland BioLabs Inc | 2012-10-25 | director |
GNLKQ | Genelink Inc | 2012-09-01 | director & CEO |
2004-07-02 | director & Chief Executive Officer | ||
2006-07-20 | director |
Bernard L Kasten Latest Holdings Summary
Bernard L Kasten currently owns a total of 2 stocks. Among these stocks, Bernard L Kasten owns 22,516 shares of Cleveland BioLabs Inc (CBLI) as of August 15, 2011, with a value of $97,945 and a weighting of 100%. Bernard L Kasten also owns 0 shares of Enzo Biochem Inc (ENZ) as of March 11, 2016, with a value of $0 and a weighting of 0%.
Latest Holdings of Bernard L Kasten
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CBLI | Cleveland BioLabs Inc | 2011-08-15 | 22,516 | 4.35 | 97,945 |
ENZ | Enzo Biochem Inc | 2016-03-11 | 0 | 1.14 | 0 |
Holding Weightings of Bernard L Kasten
Bernard L Kasten Form 4 Trading Tracker
According to the SEC Form 4 filings, Bernard L Kasten has made a total of 0 transactions in Cleveland BioLabs Inc (CBLI) over the past 5 years. The most-recent trade in Cleveland BioLabs Inc is the acquisition of 500 shares on August 15, 2011, which cost Bernard L Kasten around $25,900.
According to the SEC Form 4 filings, Bernard L Kasten has made a total of 0 transactions in Enzo Biochem Inc (ENZ) over the past 5 years. The most-recent trade in Enzo Biochem Inc is the sale of 42,782 shares on March 11, 2016, which brought Bernard L Kasten around $171,556.
Insider Trading History of Bernard L Kasten
- 1
Bernard L Kasten Trading Performance
GuruFocus tracks the stock performance after each of Bernard L Kasten's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bernard L Kasten is 2.41%. GuruFocus also compares Bernard L Kasten's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bernard L Kasten within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bernard L Kasten's insider trading performs compared to the benchmark.
Performance of Bernard L Kasten
Bernard L Kasten Ownership Network
Ownership Network List of Bernard L Kasten
Ownership Network Relation of Bernard L Kasten
Bernard L Kasten Owned Company Details
What does Enzo Biochem Inc do?
Who are the key executives at Enzo Biochem Inc?
Bernard L Kasten is the director of Enzo Biochem Inc. Other key executives at Enzo Biochem Inc include 10 percent owner James G. Wolf , Chief Executive Officer Hamid Erfanian , and Interim CFO Patricia Eckert .
Enzo Biochem Inc (ENZ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Enzo Biochem Inc (ENZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzo Biochem Inc (ENZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Enzo Biochem Inc (ENZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enzo Biochem Inc Insider Transactions
Bernard L Kasten Mailing Address
Above is the net worth, insider trading, and ownership report for Bernard L Kasten. Currently GuruFocus does not have mailing address information for Bernard L Kasten.